Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
VIGL - Vigil Neuroscience Inc - Stock Price Chart
TickerVIGL [NASD, RUT]
CompanyVigil Neuroscience Inc
CountryUSA
IndustryBiotechnology
Market Cap111.61MEPS (ttm)-2.12
P/E-EPS this Y9.96%
Forward P/E-EPS next Y-0.38%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.08EPS Q/Q2.59%
Dividend-Sales Q/Q-
Insider Own58.66%Inst Own39.10%
Insider Trans0.00%Inst Trans28.17%
Short Float5.93%EarningsMay 07/a
Analyst Recom1.50Target Price16.75
Avg Volume96.60K52W Range2.50 - 11.11
May-28-24 12:00PM All You Need to Know About Vigil Neuroscience (VIGL) Rating Upgrade to Buy (Zacks) -8.82%
May-08-24 07:40AM Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference (GlobeNewswire) +18.50%
May-07-24 10:55PM VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q1 2024 (InvestorPlace) +10.38%
09:08PM Vigil Neuroscience Inc (VIGL) Q1 2024 Earnings: Challenges Persist Amid Clinical Developments (GuruFocus.com)
04:05PM Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-17-24 04:05PM Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting (GlobeNewswire)
Mar-26-24 01:53PM VIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023 (InvestorPlace) -7.00%
07:05AM Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-20-24 07:05AM Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer (GlobeNewswire) +9.18%
Mar-13-24 07:05AM Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting (GlobeNewswire)
NUZE - Nuzee Inc - Stock Price Chart
TickerNUZE [NASD]
CompanyNuzee Inc
CountryUSA
IndustryPackaged Foods
Market Cap2.26MEPS (ttm)-9.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-3.14%
P/S0.67EPS next 5Y-
P/B-EPS Q/Q54.40%
Dividend-Sales Q/Q-22.45%
Insider Own17.76%Inst Own11.35%
Insider Trans0.00%Inst Trans-
Short Float6.59%EarningsJan 17/b
Analyst Recom1.00Target Price8.00
Avg Volume545.65K52W Range1.13 - 12.39
May-14-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-06-24 10:53PM NUZE Stock Earnings: Nuzee Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -9.22%
May-02-24 04:00PM NuZee, Inc. Announces Completion of Private Placement of Convertible Note and Warrants (PR Newswire)
Apr-29-24 07:33AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -17.18%
Apr-11-24 05:30PM NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b) (PR Newswire)
Feb-29-24 04:15PM NuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) (PR Newswire) -7.06%
Feb-14-24 04:30PM NuZee, Inc. Announces Extension for Filing of Form 10-Q (PR Newswire) +11.76%
Jan-26-24 04:15PM NuZee, Inc. Announces Receipt of NASDAQ Notification (PR Newswire)
Jan-17-24 08:30AM NuZee, Inc. Reports Full-Year Fiscal 2023 Financial Results (PR Newswire) -7.90%
Dec-29-23 04:30PM NuZee, Inc. Announces Delay in Filing Form 10-K (PR Newswire) -6.96%
LIDR - AEye Inc - Stock Price Chart
TickerLIDR [NASD]
CompanyAEye Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap28.58MEPS (ttm)-11.56
P/E-EPS this Y37.66%
Forward P/E-EPS next Y5.10%
PEG-EPS past 5Y-657.36%
P/S33.62EPS next 5Y-
P/B1.28EPS Q/Q66.14%
Dividend-Sales Q/Q-96.86%
Insider Own23.82%Inst Own8.20%
Insider Trans-20.78%Inst Trans-
Short Float23.01%EarningsMay 14/a
Analyst Recom3.00Target Price2.46
Avg Volume4.56M52W Range0.92 - 24.00
May-14-24 04:10PM AEye Reports First Quarter 2024 Results (Business Wire)
04:05PM AEye, Accelight Technologies, and LighTekton Co. Announce Partnership to Bring Lidar Solutions to China (Business Wire)
May-13-24 07:23AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
May-10-24 08:17AM Why Is AEye (LIDR) Stock Up 38% Today? (InvestorPlace) +115.00%
07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-09-24 05:00PM AEye Announces Partnership with Leading Automotive Electronics and Vision Solutions Provider, LITEON (Business Wire)
Apr-24-24 08:55AM AudioEye, Inc. (NASDAQ:AEYE) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.07%
Apr-23-24 08:55PM AEYE Stock Earnings: AudioEye Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +9.28%
08:15AM AEye to Report First Quarter 2024 Financial Results on Tuesday, May 14 (Business Wire)
Mar-27-24 10:13AM AEye, Inc. (NASDAQ:LIDR) Q4 2023 Earnings Call Transcript (Insider Monkey) -19.11%
TIRX - Tian Ruixiang Holdings Ltd - Stock Price Chart
TickerTIRX [NASD]
CompanyTian Ruixiang Holdings Ltd
CountryChina
IndustryInsurance Brokers
Market Cap10.76MEPS (ttm)-4.77
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.52EPS next 5Y-
P/B0.31EPS Q/Q96.49%
Dividend-Sales Q/Q-23.35%
Insider Own43.15%Inst Own0.14%
Insider Trans0.00%Inst Trans-
Short Float1.61%Earnings-
Analyst Recom-Target Price-
Avg Volume534.30K52W Range2.00 - 11.43
May-08-24 04:30PM TIAN RUIXIANG Holdings Ltd. Announces 1-for-5 Share Consolidation (GlobeNewswire)
Mar-25-24 04:30PM TIAN RUIXIANG Holdings Ltd Receives Notification of Non-compliance from Nasdaq Relating to Late Filing of Annual Report on Form 20-F (GlobeNewswire)
Feb-14-24 08:40AM TIAN RUIXIANG Holdings Ltd's Subsidiary Enters into Sale and Purchase Agreement for Licensed Insurance Broker in Hong Kong (GlobeNewswire) +17.68%
Jan-08-24 08:30AM TIAN RUIXIANG Holdings Ltd Enters into Memorandum of Understanding to Acquire Licensed Insurance Broker in Hong Kong (GlobeNewswire) -5.10%
Dec-05-23 04:30PM TIAN RUIXIANG Holdings Ltd Receives Nasdaq Notice of Deficiency Regarding Minimum Bid Price Requirement (GlobeNewswire)
Mar-18-23 08:39AM Tian Ruixiang Holdings Full Year 2022 Earnings: US$1.81 loss per share (vs US$1.13 loss in FY 2021) (Simply Wall St.)
Oct-27-22 04:30PM TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Six Months Ended April 30, 2022 (PR Newswire)
Jun-06-22 05:00PM TIAN RUIXIANG Holdings Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (PR Newswire)
Mar-07-22 09:00AM TIAN RUIXIANG Holdings Ltd Reports Fiscal Year 2021 Financial Results (PR Newswire) -8.92%
Dec-08-21 09:00AM TIAN RUIXIANG Holdings Ltd Announces 2021 Performance Incentive Plan (PR Newswire) -13.24%
QBTS - D-Wave Quantum Inc - Stock Price Chart
TickerQBTS [NYSE]
CompanyD-Wave Quantum Inc
CountryUSA
IndustryComputer Hardware
Market Cap179.46MEPS (ttm)-0.53
P/E-EPS this Y21.58%
Forward P/E-EPS next Y9.04%
PEG-EPS past 5Y-
P/S18.62EPS next 5Y-
P/B-EPS Q/Q46.30%
Dividend-Sales Q/Q55.72%
Insider Own5.31%Inst Own21.27%
Insider Trans0.00%Inst Trans12.70%
Short Float5.51%EarningsMay 13/b
Analyst Recom1.00Target Price3.00
Avg Volume4.02M52W Range0.57 - 3.20
May-29-24 09:52AM Here's How D-Wave Quantum (QBTS) Benefitted from Share Price Increase (Insider Monkey)
07:00AM D-Wave Quantum Featured in The Wall Street Journal (Business Wire)
May-28-24 02:00PM Do Hedge Funds Like Rigetti Computing, Inc. (NASDAQ:RGTI) As A Quantum Computing Play? (Insider Monkey) +14.75%
02:00PM Do Hedge Funds Like IonQ, Inc. (NYSE:IONQ) As A Top Quantum Computing Stock? (Insider Monkey)
02:00PM Do Hedge Funds Like D-Wave Quantum Inc. (NYSE:QBTS) As A Quantum Computing Play? (Insider Monkey)
02:00PM Arqit Quantum Inc. (NASDAQ:ARQQ) Is A Top Quantum Computing Stock (Insider Monkey)
12:59PM Is FormFactor, Inc. (NASDAQ:FORM) A Top Hedge Fund Quantum Computing Stock Pick? (Insider Monkey)
12:48PM Hedge Funds Just Picked Quantum Computing Inc. (NASDAQ:QUBT) As A Top Quantum Computing Stock (Insider Monkey)
10:21AM Is NVIDIA Corporation (NASDAQ:NVDA) The Top Quantum Computing Stock To Buy Now? (Insider Monkey)
07:00AM D-Wave Quantum Set to Join Russell 3000 Index (Business Wire)
CAVA - Cava Group Inc - Stock Price Chart
TickerCAVA [NYSE]
CompanyCava Group Inc
CountryUSA
IndustryRestaurants
Market Cap10.05BEPS (ttm)0.25
P/E346.54EPS this Y56.07%
Forward P/E203.63EPS next Y32.10%
PEG10.80EPS past 5Y-
P/S12.81EPS next 5Y32.10%
P/B17.31EPS Q/Q730.85%
Dividend-Sales Q/Q27.54%
Insider Own20.66%Inst Own72.09%
Insider Trans-23.04%Inst Trans-
Short Float12.79%EarningsMay 28/a
Analyst Recom1.81Target Price70.74
Avg Volume2.53M52W Range29.05 - 86.25
Today 01:01AM Decoding Cava Group Inc (CAVA): A Strategic SWOT Insight (GuruFocus.com)
May-29-24 04:10PM Cava Rebounds To Record High After Earnings Beat, But Traffic Declines (Investor's Business Daily) +6.99%
12:56PM Cava Rebounds After Earnings Beat, But Traffic Declines (Investor's Business Daily)
11:43AM Cava stock slides after a slowdown in same-store sales growth (Yahoo Finance Video)
11:34AM Cava Earnings Beat, But Traffic Decline Drags On Stock (Investor's Business Daily)
09:30AM CAVA Group (CAVA) Q1 Earnings & Revenues Beat Estimates (Zacks)
08:03AM CAVA Group, Inc. (NYSE:CAVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:37AM Cava Earnings Beat Estimates. Why the Stock Is Dropping. (Barrons.com)
May-28-24 08:53PM CAVA Stock Earnings: Cava Group Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM Cava Group (CAVA) Q1 2024 Earnings Call Transcript (Motley Fool)
WORX - SCWorx Corp - Stock Price Chart
TickerWORX [NASD]
CompanySCWorx Corp
CountryUSA
IndustryHealth Information Services
Market Cap2.71MEPS (ttm)-1.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.68%
P/S0.69EPS next 5Y-
P/B0.43EPS Q/Q-53.45%
Dividend-Sales Q/Q-8.19%
Insider Own6.28%Inst Own2.71%
Insider Trans0.00%Inst Trans-35.91%
Short Float2.59%Earnings-
Analyst Recom-Target Price-
Avg Volume2.34M52W Range1.14 - 14.40
May-21-24 02:37PM SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended March 31, 2024 (GlobeNewswire)
Apr-26-24 07:49AM Top Premarket Decliners (MT Newswires) -15.22%
Apr-23-24 03:45PM SCWorx Corp. Receives Expected Notice from NASDAQ Stock Market Pertaining to its 10-K of December 31, 2023 (GlobeNewswire) -7.80%
Dec-14-23 07:03AM WORX Stock Earnings: SCWorx Reported Results for Q3 2023 (InvestorPlace)
Oct-23-23 09:30AM SCWorx Signs Letter of Intent to Acquire an Environmental Services Company (GlobeNewswire) -5.83%
Oct-10-23 12:21PM SCWorx Shareholders Overwhelmingly Approve Reverse Stock Split at Annual Meeting (GlobeNewswire)
Apr-25-23 10:41AM New York Hospital Selects SCWorx for Data Management and Workday Implementation Assistance (GlobeNewswire) -6.54%
Jan-30-23 02:45PM SCWorx Announces New Hospital Customer (GlobeNewswire)
Dec-13-22 10:27AM SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Sep-06-22 11:06AM SCWorx Announces New Product and the Signing of Two New Hospital Customers (GlobeNewswire)
EGRX - Eagle Pharmaceuticals Inc - Stock Price Chart
TickerEGRX [NASD, RUT]
CompanyEagle Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap43.39MEPS (ttm)0.91
P/E3.67EPS this Y-
Forward P/E-EPS next Y-
PEG1.36EPS past 5Y-3.56%
P/S0.17EPS next 5Y2.70%
P/B0.17EPS Q/Q153.33%
Dividend-Sales Q/Q-12.80%
Insider Own12.02%Inst Own81.50%
Insider Trans0.00%Inst Trans-1.44%
Short Float9.96%EarningsNov 16/b
Analyst Recom3.00Target Price17.00
Avg Volume149.08K52W Range3.50 - 23.52
May-22-24 09:00AM Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq (GlobeNewswire) -12.81%
Apr-30-24 08:00AM Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida (GlobeNewswire) +13.29%
Apr-12-24 04:05PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K (GlobeNewswire)
Feb-05-24 09:55AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Feb-01-24 04:05PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-26-24 12:33PM EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline February 9, 2024 (GlobeNewswire)
Jan-24-24 09:45AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-18-24 06:50AM Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio (GlobeNewswire)
Jan-12-24 10:12AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
RVYL - Ryvyl Inc - Stock Price Chart
TickerRVYL [NASD]
CompanyRyvyl Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap9.06MEPS (ttm)-8.81
P/E-EPS this Y84.08%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-51.16%
P/S0.13EPS next 5Y-
P/B0.41EPS Q/Q70.62%
Dividend-Sales Q/Q48.56%
Insider Own36.50%Inst Own3.37%
Insider Trans0.00%Inst Trans-72.82%
Short Float4.11%EarningsMay 14/a
Analyst Recom1.00Target Price25.00
Avg Volume93.15K52W Range1.12 - 17.50
May-20-24 08:00AM RYVYL Extends its Obligation to Repay Convertible Note to April 2026 (GlobeNewswire) -6.41%
May-15-24 03:09AM Ryvyl Inc (RVYL) Q1 2024 Earnings Call Transcript Highlights: Soaring International Revenues ... (GuruFocus.com) +11.76%
May-14-24 04:05PM RYVYL Reports Q1 2024 Results (GlobeNewswire)
May-07-24 09:34AM Q2 2024 Symbotic Inc Earnings Call (Thomson Reuters StreetEvents) +6.99%
May-06-24 08:00AM RYVYL to Announce First Quarter 2023 Financial Results on Tuesday, May 14, 2024 (GlobeNewswire)
Apr-16-24 08:34AM Why Is Ryvyl (RVYL) Stock Down 10% Today? (InvestorPlace) -36.44%
08:28AM RYVYL Inc. Announces Cancellation of Proposed Underwritten Public Offering (GlobeNewswire)
Apr-15-24 04:27PM RYVYL Inc. Announces Launch of Proposed Underwritten Public Offering (GlobeNewswire)
Mar-27-24 12:39PM Ryvyl Inc. (NASDAQ:RVYL) Q4 2023 Earnings Call Transcript (Insider Monkey) -32.20%
Mar-26-24 08:53PM RVYL Stock Earnings: Ryvyl Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +7.47%
INDP - Indaptus Therapeutics Inc - Stock Price Chart
TickerINDP [NASD]
CompanyIndaptus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap23.57MEPS (ttm)-1.78
P/E-EPS this Y-4.64%
Forward P/E-EPS next Y27.15%
PEG-EPS past 5Y56.03%
P/S-EPS next 5Y-
P/B2.52EPS Q/Q10.94%
Dividend-Sales Q/Q-
Insider Own30.86%Inst Own6.88%
Insider Trans0.00%Inst Trans12.55%
Short Float0.28%EarningsMay 08/b
Analyst Recom1.00Target Price10.00
Avg Volume88.73K52W Range1.56 - 4.08
May-29-24 08:00AM Indaptus Therapeutics to Present New Cohort Data Confirming Original Pulse-Prime Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting (GlobeNewswire) +12.20%
May-22-24 08:00AM Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company's Broad-Based, Pulse-Prime Immuno-Oncology Therapy for Advanced Solid Tumors (GlobeNewswire) +5.53%
May-08-24 12:54PM INDP Stock Earnings: Indaptus Therapeutics Misses EPS for Q1 2024 (InvestorPlace)
08:00AM Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-11-24 07:30AM Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting (GlobeNewswire) +9.13%
Mar-28-24 08:00AM Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference (GlobeNewswire) -10.04%
Mar-25-24 08:30AM Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting (GlobeNewswire) +6.90%
Mar-18-24 08:00AM Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 (GlobeNewswire)
Mar-13-24 07:30AM Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-04-24 07:30AM Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort (GlobeNewswire) +12.92%
1234567891011⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.